WO1998014577B1 - Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation - Google Patents
Sequence nucleotique et de proteique de mammastatine et procedes d'utilisationInfo
- Publication number
- WO1998014577B1 WO1998014577B1 PCT/US1997/018026 US9718026W WO9814577B1 WO 1998014577 B1 WO1998014577 B1 WO 1998014577B1 US 9718026 W US9718026 W US 9718026W WO 9814577 B1 WO9814577 B1 WO 9814577B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mammastatin
- kda
- composition
- dna sequence
- nucleic acid
- Prior art date
Links
- 108010016172 mammastatin Proteins 0.000 title claims abstract 30
- 108090000623 proteins and genes Chemical group 0.000 title claims 2
- 102000004169 proteins and genes Human genes 0.000 title claims 2
- 239000002773 nucleotide Substances 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims abstract 11
- 150000007523 nucleic acids Chemical group 0.000 claims abstract 6
- 230000012010 growth Effects 0.000 claims abstract 4
- 206010006187 Breast cancer Diseases 0.000 claims abstract 3
- 206010061289 Metastatic neoplasm Diseases 0.000 claims abstract 2
- 230000010261 cell growth Effects 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 8
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 3
- 201000009030 carcinoma Diseases 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 229920001405 Coding region Polymers 0.000 claims 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 210000001519 tissues Anatomy 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000001124 Body Fluids Anatomy 0.000 claims 1
- 102000007312 Recombinant Proteins Human genes 0.000 claims 1
- 108010033725 Recombinant Proteins Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 abstract 1
- 230000001394 metastastic Effects 0.000 abstract 1
Abstract
L'invention concerne une séquence nucléotidique codant pour la mammastatine, un inhibiteur de croissance spécifique de cellule mammaire. La mammastatine est codée par une seule séquence nucléotidique, et possède un poids moléculaire approximatif de 44 kDa dans sa forme inactive, non phosphorylée. Les cellules mammaires normales expriment des formes phosphorylées fonctionnelles possédant des poids moléculaires approximatifs de 53 kDa et 49 kDa. Des cellules mammaires métastatiques, ou n'expriment pas du tout la mammastatine, ou n'expriment pas les formes phosphorylées à 53 kDa ou 49 kDa. L'administration de mammastatine phosphorylée permet d'inhiber la croissance de cellules mammaires cancéreuses.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51695598A JP4452331B2 (ja) | 1996-10-03 | 1997-10-03 | ママスタチンのヌクレオチドおよびタンパク質配列およびその使用法 |
| CA2267095A CA2267095C (fr) | 1996-10-03 | 1997-10-03 | Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation |
| EP97945531A EP0929675A2 (fr) | 1996-10-03 | 1997-10-03 | Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation |
| IL12924197A IL129241A0 (en) | 1996-10-03 | 1997-10-03 | Nucleotide and protein sequence of mammastatin and methods of use |
| EA199900256A EA199900256A1 (ru) | 1996-10-03 | 1997-10-03 | Нуклеотидная и белковая последовательность маммастатина и способы применения |
| BR9713248-9A BR9713248A (pt) | 1996-10-03 | 1997-10-03 | Sequência de nucleotìdeos e de proteìnas de mamastatina e processos de uso |
| AU46709/97A AU733380B2 (en) | 1996-10-03 | 1997-10-03 | Nucleotide and protein sequence of mammastatin and methods of use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2731596P | 1996-10-03 | 1996-10-03 | |
| US60/027,315 | 1996-10-03 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| WO1998014577A3 WO1998014577A3 (fr) | 1998-04-09 |
| WO1998014577A2 WO1998014577A2 (fr) | 1998-04-09 |
| WO1998014577B1 true WO1998014577B1 (fr) | 1998-07-30 |
| WO1998014577A9 WO1998014577A9 (fr) | 1998-08-27 |
Family
ID=21836977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/018026 WO1998014577A2 (fr) | 1996-10-03 | 1997-10-03 | Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US6451765B1 (fr) |
| EP (2) | EP1935899A1 (fr) |
| JP (2) | JP4452331B2 (fr) |
| AU (1) | AU733380B2 (fr) |
| BR (1) | BR9713248A (fr) |
| CA (1) | CA2267095C (fr) |
| EA (1) | EA199900256A1 (fr) |
| WO (1) | WO1998014577A2 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500937B1 (en) * | 1996-10-03 | 2002-12-31 | University Of Michigan | Nucleotide sequence encoding a mammary cell growth inhibitor |
| EP1935899A1 (fr) * | 1996-10-03 | 2008-06-25 | The Regents Of The University Of Michigan | Nucléotide et séquence de protéine de mammastatine et procédés d'utilisation |
| US6939714B2 (en) | 1999-06-18 | 2005-09-06 | Biotherapies, Inc. | Epithelial cell growth inhibitors |
| MXPA01013242A (es) * | 1999-06-18 | 2002-11-04 | Biotherapies Inc | Inhibidores del crecimiento de celulas epiteliales. |
| JP5118796B2 (ja) | 1999-06-28 | 2013-01-16 | ジェネンテック， インコーポレイテッド | 二価の金属イオンを利用したＡｐｏ−２リガンドの製造方法 |
| WO2001098496A1 (fr) * | 2000-06-19 | 2001-12-27 | The University Of Michigan | Allele c de sequence de mammastatine |
| US20030212263A1 (en) * | 2000-06-19 | 2003-11-13 | The University Of Michigan | Mammastatin sequence variant C |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4379839A (en) | 1977-05-23 | 1983-04-12 | The Trustees Of Columbia University In The City Of New York | Method for detecting cancer |
| US4753894A (en) | 1984-02-08 | 1988-06-28 | Cetus Corporation | Monoclonal anti-human breast cancer antibodies |
| WO1989011492A1 (fr) * | 1988-05-20 | 1989-11-30 | The Regents Of The University Of Michigan | Inhibiteur de croissance de cellules mammaires humaines et procedes de production et d'utilisation |
| EP0417168A4 (en) * | 1988-05-20 | 1991-09-11 | The Regents Of The University Of Michigan | Antibodies to human mammary cell growth inhibitor and methods of production and use |
| US6500937B1 (en) * | 1996-10-03 | 2002-12-31 | University Of Michigan | Nucleotide sequence encoding a mammary cell growth inhibitor |
| EP1935899A1 (fr) * | 1996-10-03 | 2008-06-25 | The Regents Of The University Of Michigan | Nucléotide et séquence de protéine de mammastatine et procédés d'utilisation |
-
1997
- 1997-10-03 EP EP07019672A patent/EP1935899A1/fr not_active Withdrawn
- 1997-10-03 BR BR9713248-9A patent/BR9713248A/pt not_active Application Discontinuation
- 1997-10-03 EA EA199900256A patent/EA199900256A1/ru unknown
- 1997-10-03 CA CA2267095A patent/CA2267095C/fr not_active Expired - Fee Related
- 1997-10-03 JP JP51695598A patent/JP4452331B2/ja not_active Expired - Fee Related
- 1997-10-03 AU AU46709/97A patent/AU733380B2/en not_active Ceased
- 1997-10-03 WO PCT/US1997/018026 patent/WO1998014577A2/fr active Application Filing
- 1997-10-03 EP EP97945531A patent/EP0929675A2/fr not_active Ceased
-
1999
- 1999-04-02 US US09/285,379 patent/US6451765B1/en not_active Expired - Fee Related
- 1999-08-06 US US09/369,912 patent/US6492504B2/en not_active Expired - Fee Related
-
2002
- 2002-07-09 US US10/192,915 patent/US7332287B2/en not_active Expired - Fee Related
- 2002-07-09 US US10/193,524 patent/US7323173B2/en not_active Expired - Fee Related
-
2008
- 2008-02-07 US US12/027,799 patent/US20090011434A1/en not_active Abandoned
-
2009
- 2009-08-14 JP JP2009188028A patent/JP2010031013A/ja active Pending
-
2010
- 2010-09-22 US US12/888,214 patent/US20110039279A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5922572A (en) | Polynucleotides encoding haemopoietic maturation factor | |
| Dobashi et al. | Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas | |
| HUP0004611A2 (hu) | APRIL, egy új növekedési hatású fehérje | |
| KR970707141A (ko) | 종양 괴사 인자-감마(Tumor necrosis factor-gamma) | |
| NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
| KR950701379A (ko) | neu 수용체의 재조합 자극인자(RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR) | |
| CA2240516A1 (fr) | Nouveaux recepteurs du type tyrosine kinase et ligands | |
| US6180602B1 (en) | Human novel cDNA, TGF-beta superfamily protein encoded thereby and the use of immunosuppressive agent | |
| JP2013231052A (ja) | 炎症性疾患および障害を治療するための医薬組成物及びキット | |
| US5985822A (en) | Inhibition of glial cell proliferation with N-CAM homophilic peptides | |
| CA2623635A1 (fr) | Compositions et procedes d'utilisation de mutants des chondroitinases abci | |
| WO1998014577B1 (fr) | Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation | |
| CA2267095A1 (fr) | Sequence nucleotique et de proteique de mammastatine et procedes d'utilisation | |
| KR20010021768A (ko) | 제암제 | |
| US5157106A (en) | N-terminal deletions of lymphotoxin, their preparation and use | |
| KR102127218B1 (ko) | 뇌 신경 교종 치료용 약물 제조에서의 화합물의 용도 | |
| CA2170393A1 (fr) | Clonage d'un membre de la famille serine-threonine-kinase | |
| CN113501870A (zh) | 一种乳源多肽及其嵌合肽在用于制备促进脂肪细胞能量代谢药物中的应用 | |
| KR20070059009A (ko) | 뮤신3 ｅｇｆ-유사 도메인 | |
| EP0806477B1 (fr) | Utilisation, pour la fabrication d'un medicament, d'un adn recombinant comprenant un adn codant pour la proteine isoforme sm1 de la chaine lourde de la myosine de type muscle lisse | |
| EP1316315B1 (fr) | Facteur thymique sérique pour le traitement de maladies de stress oxidatif dans les reactions allergiques | |
| AU783373B2 (en) | Epithelial cell growth inhibitors | |
| Yamada et al. | p33, an endogenous target protein for arginine‐specific ADP‐ribosyltransferase in chicken polymorphonuclear leukocytes, is highly homologous to mim‐1 protein (myb‐induced myeloid protein‐1) | |
| CN109689079A (zh) | 牛成纤维细胞生长因子21和乳畜中的酮病 | |
| US20040106550A1 (en) | Remedies for arthritis deformans and remedies for rheumatoid arthritis |